-
公开(公告)号:US20240425602A1
公开(公告)日:2024-12-26
申请号:US18424004
申请日:2024-01-26
Applicant: Novartis AG
Inventor: Catrin BERGER , Tanja HERRMANN , Chris LU , Kelly-Ann SHEPPARD , Estelle TRIFILIEFF , Stefanie URLINGER
IPC: C07K16/28 , A61K39/00 , A61K39/395 , A61K45/06 , C07H21/04
Abstract: This disclosure is in the field of anti-Activin receptor IIB (ActRIIB) antibodies. In particular, it relates to the use of said antibodies for treating muscle disorders, such as muscle wasting due to disease or disuse.